Evidence map›Paper›PMID 32442756›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020

Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19.

Liping Sun, Fengxiang Song, Nannan Shi, Fengjun Liu, Shenyang Li, Ping Li, Weihan Zhang, Xiao Jiang, Yongbin Zhang, Lining Sun and 2 more

Abstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Liping SunShanghai University of Medicine & Health Sciences, No.257 Tianxiong Road, Pudong New Area, Shanghai, 201318, PR China. Electronic address: sunlp@sumhs.edu.cn.
Fengxiang SongShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Nannan ShiShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Fengjun LiuShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Shenyang LiShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Ping LiShanghai University of Medicine & Health Sciences, No.257 Tianxiong Road, Pudong New Area, Shanghai, 201318, PR China.
Weihan ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Xiao Jiang905th Hospital of PLA, Shanghai, 200052, PR China.
Yongbin ZhangShanghai University of Medicine & Health Sciences, No.257 Tianxiong Road, Pudong New Area, Shanghai, 201318, PR China.
Lining SunShanghai University of Medicine & Health Sciences, No.257 Tianxiong Road, Pudong New Area, Shanghai, 201318, PR China; School of Mechanical and Electrical Engineering, SooChow University, PR China. Electronic address: lnsun@hit.edu.cn.
Xiong ChenShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China.
Yuxin ShiShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, PR China. Electronic address: shiyx828288@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the death rate of COVID-19 is less than 3%, the fatality rate of severe/critical cases is high, according to World Health Organization (WHO). Thus, screening the severe/critical cases before symptom occurs effectively saves medical resources. METHODS AND MATERIALS: In this study, all 336 cases of patients infected COVID-19 in Shanghai to March 12th, were retrospectively enrolled, and divided in to training and test datasets. In addition, 220 clinical and laboratory observations/records were also collected. Clinical indicators were associated with severe/critical symptoms were identified and a model for severe/critical symptom prediction was developed.

resultsTotally, 36 clinical indicators significantly associated with severe/critical symptom were identified. The clinical indicators are mainly thyroxine, immune related cells and products. Support Vector Machine (SVM) and optimized combination of age, GSH, CD3 ratio and total protein has a good performance in discriminating the mild and severe/critical cases. The area under receiving operating curve (AUROC) reached 0.9996 and 0.9757 in the training and testing dataset, respectively. When the using cut-off value as 0.0667, the recall rate was 93.33 % and 100 % in the training and testing datasets, separately. Cox multivariate regression and survival analyses revealed that the model significantly discriminated the severe/critical cases and used the information of the selected clinical indicators.

conclusionThe model was robust and effective in predicting the severe/critical COVID cases.

Indexed as

Disease OutbreaksAdultAgedAge FactorsArea Under CurveBetacoronavirusBiomarkersCD3 ComplexCohort StudiesCoronary DiseaseCoronavirus InfectionsCOVID-19Diabetes ComplicationsDiabetes MellitusFemaleGlutathioneBiomarkersCD3 ComplexGlutathioneThyroxineCOVID-19critical/severe symptomPredictionSVM

Identifiers

PMID32442756
PMCPMC7219384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.